AETHLON MEDICAL INC
AETHLON MEDICAL INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 5 | 5 | 7 | 6 | 4 | 6 | 5 | 7 | 9 | 5 | 8 | 10 | |||||
Cash | - | - | - | - | - | - | - | - | - | - | 8 | 10 | |||||
Deferred Offering Costs | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
Assets Current | 6 | 6 | 7 | 6 | 4 | 6 | 5 | 7 | 10 | 6 | 8 | 10 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Finite Lived Intangible Assets Net | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Restricted Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Restricted Cash Noncurrent | - | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Deposits Assets Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 6 | 6 | 8 | 7 | 5 | 7 | 7 | 9 | 11 | 8 | 10 | 13 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Professional Fees Current | - | - | - | - | - | - | 0 | 0 | - | - | - | - | |||||
Other Liabilities Current | 0 | 1 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Operating Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |||||
Liabilities | - | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 182 | 180 | 180 | 177 | 173 | 173 | 166 | 166 | 166 | 160 | 160 | 159 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -177 | -175 | -173 | -171 | -170 | -168 | -162 | -160 | -157 | -155 | -152 | -149 | |||||
Stockholders Equity | 5 | 5 | 7 | 6 | 3 | 5 | 4 | 6 | 9 | 6 | 8 | 10 | |||||
Liabilities And Stockholders Equity | 6 | 6 | 8 | 7 | 5 | 7 | 7 | 9 | 11 | 8 | 10 | 13 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 20 | 6 | 6 | 6 | 60 | 6 | 60 | 60 | 60 | 60 | 60 | 60 | |||||
Common Stock Shares Issued | 0 | 2 | 1 | 1 | 3 | 0 | 2 | 2 | 2 | 0 | 0 | 0 | |||||
Shares Outstanding | 0 | 2 | 1 | 1 | 3 | 0 | 2 | 2 | 2 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | -41.46% | -35.77% | -57.24% | -11.90% | -32.86% | -40.48% | -14.14% | 7.07% | 16.16% | -64.85% | -67.33% | - |
| 2025 | -7.89% | 15.79% | 0.00% | -4.88% | 95.12% | 70.73% | -34.33% | -47.76% | -40.30% | -33.51% | -41.24% | -60.31% |
| 2024 | - | - | - | 21.69% | 26.51% | 8.43% | -2.31% | 1.16% | -19.65% | -29.31% | -29.31% | -34.48% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 5.42 | 3.85 | 5.68 | 4.45 | 2.49 | 3.13 | 2.80 | 3.06 | 4.49 | 3.40 | 3.93 | 6.13 | |||||
| Quick Ratio | 5.14 | 3.62 | 5.53 | 4.32 | 2.32 | 2.90 | 2.75 | 2.94 | 4.26 | 3.13 | 3.80 | 5.95 | |||||
| Working Capital | 4.57M | 4.12M | 5.88M | 4.85M | 2.42M | 4.05M | 3.19M | 4.81M | 7.42M | 4.40M | 6.15M | 8.78M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.20 | 0.30 | 0.20 | 0.27 | 0.55 | 0.44 | 0.51 | 0.47 | 0.31 | 0.43 | 0.37 | 0.24 | |||||
| Interest Coverage TTM | -72.33 | -75.09 | -17.12 | -15.95 | -16.40 | -19.13 | -15.29 | -16.94 | -16.25 | -17.33 | -52.21 | -84.54 | |||||
| Debt Ratio | 0.17 | 0.23 | 0.17 | 0.22 | 0.35 | 0.30 | 0.34 | 0.32 | 0.24 | 0.30 | 0.27 | 0.20 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.03 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -18.03 | -10.61 | -14.00 | -28.32 | -302.88 | -85.77 | -54.77 | -64.69 | -12.33 | -38.87 | -38.94 | -37.47 | |||||
| Free Cash Flow Per Share TTM | -18.67 | -10.39 | -8.41 | -17.76 | -0.18 | -49.01 | -48.96 | -51.19 | -10.10 | -33.05 | -34.23 | -33.77 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | - | - | - | - | - | - | - | -2,199.08% | -2,074.16% | |||||
| Net Profit Margin TTM | - | - | - | - | - | - | - | - | - | - | -2,133.18% | -2,025.85% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | - | -100.00% | -100.00% | -100.00% | -100.00% | 4,278.20% | 1,799.40% | |||||
| Net Income Growth (1Y) | -44.85% | -46.58% | 20.54% | -0.10% | 9.40% | 9.66% | -21.97% | -3.12% | -7.33% | 1.48% | -8.24% | -10.70% | |||||
| EPS Growth (1Y) | 5,853.86% | -87.63% | -74.44% | -56.22% | -97.54% | 120.68% | 40.64% | 72.63% | -69.79% | -17.06% | -16.33% | -25.41% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.23 | -1.03 | -0.99 | -1.32 | -198.10 | -1.68 | -6.28 | -2.91 | -16.22 | -17.29 | -22.50 | -24.55 | |||||
| P/B TTM | 0.30 | 1.51 | 1.70 | 2.59 | 727.83 | 4.39 | 13.85 | 5.44 | 21.40 | 36.60 | 36.20 | 27.68 | |||||
| P/S TTM | - | - | - | - | - | - | - | - | - | - | 479.86 | 497.38 | |||||
| Market Cap | 1.58M | 7.38M | 11.40M | 14.91M | 2.49B | 22.48M | 60.04M | 32.75M | 186.45M | 211.07M | 275.56M | 285.62M | |||||
| Enterprise Value | -3.46M | 2.25M | 4.35M | 8.95M | 2.49B | 16.88M | 55.21M | 25.89M | 177.38M | 205.54M | 267.59M | 275.44M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -7.18M | -7.00M | -6.92M | -7.06M | -7.62M | -7.65M | -8.55M | -8.92M | -9.42M | -10.38M | -10.77M | -10.48M | |||||
| Net Debt | -5.03M | -5.13M | -7.06M | -5.95M | -3.77M | -5.60M | -4.83M | -6.86M | -9.07M | -5.53M | -7.97M | -10.18M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
AETHLON MEDICAL INC (AEMD) — SEC Financial Statements & Analysis
AETHLON MEDICAL INC (AEMD) is a surgical & medical instruments & apparatus company, incorporated in NV. AETHLON MEDICAL INC trades on Nasdaq as: AEMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), AETHLON MEDICAL INC reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.20x, a Price-to-Sales (P/S) ratio of 479.86x (TTM), a Price-to-Book (P/B) ratio of 0.30x (TTM), at a market cap of $1.58M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- 0.20x
- P/S TTM
- 479.86x
- P/B TTM
- 0.30x
- Market Cap
- $1.58M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AETHLON MEDICAL INC in?
AETHLON MEDICAL INC (AEMD) operates in the Surgical & Medical Instruments & Apparatus industry.
What is AEMD's market cap?
AETHLON MEDICAL INC (AEMD) has a market capitalization of $1.58M as of 2026-06-30.
What exchange does AEMD trade on?
AETHLON MEDICAL INC (AEMD) trades on the Nasdaq.
Where is AETHLON MEDICAL INC incorporated?
AETHLON MEDICAL INC is incorporated in NV.